16.86
Fulgent Genetics Inc stock is traded at $16.86, with a volume of 419.54K.
It is down -0.82% in the last 24 hours and up +8.63% over the past month.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.
See More
Previous Close:
$17.00
Open:
$16.59
24h Volume:
419.54K
Relative Volume:
1.06
Market Cap:
$520.40M
Revenue:
$290.71M
Net Income/Loss:
$-163.43M
P/E Ratio:
-3.0766
EPS:
-5.48
Net Cash Flow:
$11.70M
1W Performance:
-1.11%
1M Performance:
+8.63%
6M Performance:
-19.29%
1Y Performance:
-20.51%
Fulgent Genetics Inc Stock (FLGT) Company Profile
Name
Fulgent Genetics Inc
Sector
Industry
Phone
626-350-0537
Address
4399 SANTA ANITA AVE, EL MONTE
Compare FLGT with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
FLGT
Fulgent Genetics Inc
|
16.86 | 520.40M | 290.71M | -163.43M | 11.70M | -5.48 |
![]()
TMO
Thermo Fisher Scientific Inc
|
437.91 | 165.21B | 42.88B | 6.34B | 7.27B | 16.53 |
![]()
DHR
Danaher Corp
|
181.77 | 130.05B | 23.88B | 3.90B | 5.30B | 5.28 |
![]()
IDXX
Idexx Laboratories Inc
|
393.73 | 31.91B | 3.90B | 887.87M | 798.08M | 10.67 |
![]()
A
Agilent Technologies Inc
|
103.00 | 29.38B | 6.53B | 1.26B | 1.31B | 4.35 |
![]()
IQV
Iqvia Holdings Inc
|
154.73 | 27.28B | 15.41B | 1.37B | 2.11B | 7.50 |
Fulgent Genetics Inc Stock (FLGT) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Dec-07-23 | Initiated | UBS | Neutral |
Dec-08-22 | Downgrade | Piper Sandler | Overweight → Neutral |
Nov-18-22 | Initiated | Raymond James | Outperform |
Aug-25-22 | Initiated | Credit Suisse | Outperform |
Feb-04-22 | Resumed | Piper Sandler | Overweight |
Aug-05-21 | Resumed | Credit Suisse | Underperform |
Jan-08-21 | Downgrade | Credit Suisse | Neutral → Underperform |
Nov-24-20 | Downgrade | BTIG Research | Buy → Neutral |
Aug-20-20 | Initiated | Oppenheimer | Outperform |
May-29-20 | Initiated | BTIG Research | Buy |
Nov-05-19 | Upgrade | Piper Jaffray | Neutral → Overweight |
Mar-01-18 | Downgrade | Piper Jaffray | Overweight → Neutral |
Nov-07-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
View All
Fulgent Genetics Inc Stock (FLGT) Latest News
Short Interest in Fulgent Genetics, Inc. (NASDAQ:FLGT) Increases By 19.6% - MarketBeat
Diametric Capital LP Acquires Shares of 38,818 Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat
Quantbot Technologies LP Has $192,000 Position in Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World
Where are the Opportunities in (FLGT) - news.stocktradersdaily.com
Charles Schwab Investment Management Inc. Has $3.88 Million Position in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat
Proficio Capital Partners LLC Purchases New Holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat
PNC Financial Services Group Inc. Sells 2,046 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World
Fulgent Genetics, Inc. (NASDAQ:FLGT) Shares Bought by Intech Investment Management LLC - MarketBeat
Magnetar Financial LLC Invests $314,000 in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat
A better buy-in window may exist right now for Fulgent Genetics Inc (FLGT) - SETE News
Bank of New York Mellon Corp Sells 38,099 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat
Connor Clark & Lunn Investment Management Ltd. Purchases 112,011 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat
Fulgent Genetics Inc (FLGT) Shares Up 1.18% on Mar 22 - GuruFocus.com
Amundi Boosts Stake in Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World
Fulgent Genetics Inc (FLGT) Shares Up 0.12% on Mar 21 - GuruFocus.com
(FLGT) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Fulgent Genetics: Undervalued, CFO Buying, And Promising Drug Candidates Make It A Buy - Seeking Alpha
Fulgent Genetics Inc (FLGT) Getting Ready To Launch, Waiting For The Long Term Buyers - Stocks Register
AlphaQuest LLC Buys 27,085 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat
Proficio Capital Partners LLC Acquires Shares of 22,238 Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat
Fulgent Genetics (NASDAQ:FLGT) Sees Large Volume IncreaseStill a Buy? - MarketBeat
Proficio Capital Partners LLC Purchases New Position in Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World
Fulgent Genetics (NASDAQ:FLGT) Shares Gap Up on Insider Buying Activity - MarketBeat
Fulgent Genetics, Inc. (NASDAQ:FLGT) Short Interest Update - MarketBeat
Fulgent Genetics (NASDAQ:FLGT) Upgraded to Hold at StockNews.com - MarketBeat
Piper Sandler Issues Pessimistic Forecast for Fulgent Genetics (NASDAQ:FLGT) Stock Price - MarketBeat
Fulgent Genetics, Inc. to Host Earnings Call - ACCESS Newswire
Fulgent Genetics Chief Financial Officer Acquires 40% More Stock - Simply Wall St
Insider Buying: Fulgent Genetics, Inc. (NASDAQ:FLGT) CFO Buys 100,000 Shares of Stock - MarketBeat
Fulgent Genetics CFO Paul Kim purchases $1.6 million in company stock By Investing.com - Investing.com South Africa
Fulgent Genetics CFO Makes a Major Stock Purchase! - TipRanks
Insider Buying: Paul Kim Acquires 100,000 Shares of Fulgent Gene - GuruFocus.com
Fulgent Genetics Inc Stock (FLGT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):